Both in Biotechnology
Aligos Therapeutics vs INmune Bio
Over the past year ALGS returned −36.3% and INMB returned −19.4%; their daily moves had a correlation of 0.28.
ALGS −36.3% INMB −19.4%Growth of $1, one year, split-adjusted
| Metric | ALGS | INMB |
|---|---|---|
| Price | $4.80 | $1.45 |
| Market cap | $30.0M | $44.9M |
| Today | −4.57% | −9.38% |
| 1 month | −12.7% | −24.9% |
| 6 months | −21.2% | −4.0% |
| Year to date | −48.5% | −7.1% |
| 1 year | −44.3% | −20.3% |
| Revenue growth (YoY) | +2778.5% | — |
| Gross margin | 100.0% | — |
| Net margin | −5.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | — |
| Net cash | $30.3M | $18.4M |
| Dividend yield | — | — |
| Volatility (60d) | 91.6% | 67.2% |
| Short % of float | 12.7% | 11.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).